This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Progenics Pharmaceuticals, Inc.
Drug Names(s): GMK
Description: GMK incorporates an immune stimulant or adjuvant and the GM2 ganglioside, a cancer antigen present in approximately 95% of melanoma cells.
Antigenics' QS-21 adjuvant is a component of GMK.
Partners: Agenus Inc.
Additional information available to subscribers only: